RCC1 and glioblastoma: In glioblastoma, CK2 was reported to phosphorylate and stabilize PRMT6, which enhances the methylation of RCC1, thereby facilitating RCC1 localization in chromatin and contributing to tumorigenicity and progression of glioblastoma [29].